Phlox Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.07M

  • Investors
  • 6

Phlox Therapeutics General Information

Description

Developer of gene therapeutics intended to alleviate and cure different heart diseases. The company's technology includes gene therapy, an RNA-based therapeutic product and other cardiac therapeutics providing lifelong benefits, enabling patients to reduce the negative effects caused by genetic mutations and to access therapeutic technology that can cure genetic heart diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands

Phlox Therapeutics Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phlox Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 06-Nov-2024 $2.07M Completed Pre-Clinical Trials
2. Seed Round 18-Aug-2023 Completed Pre-Clinical Trials
1. Seed Round 16-May-2022 Completed Pre-Clinical Trials
To view Phlox Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Phlox Therapeutics Patents

Phlox Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025064905-A1 Therapeutic constructs and related methods to treat rbm20-related cardiomyopathy Inactive 20-Sep-2023

Phlox Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phlox Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
ROM Utrecht Region Impact Investing Minority
Innovatiefonds Noord-Holland Venture Capital Minority
Utrecht Health Seed Fund Venture Capital Minority
UvA Ventures Holding Venture Capital Minority
Amsterdam UMC Ventures Holding Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Phlox Therapeutics FAQs

  • When was Phlox Therapeutics founded?

    Phlox Therapeutics was founded in 2022.

  • Where is Phlox Therapeutics headquartered?

    Phlox Therapeutics is headquartered in Naarden, Netherlands.

  • What is the size of Phlox Therapeutics?

    Phlox Therapeutics has 7 total employees.

  • What industry is Phlox Therapeutics in?

    Phlox Therapeutics’s primary industry is Biotechnology.

  • Is Phlox Therapeutics a private or public company?

    Phlox Therapeutics is a Private company.

  • What is Phlox Therapeutics’s current revenue?

    The current revenue for Phlox Therapeutics is .

  • How much funding has Phlox Therapeutics raised over time?

    Phlox Therapeutics has raised $2.07M.

  • Who are Phlox Therapeutics’s investors?

    ROM Utrecht Region, Innovatiefonds Noord-Holland, Utrecht Health Seed Fund, UvA Ventures Holding, and Amsterdam UMC Ventures Holding are 5 of 6 investors who have invested in Phlox Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process